[1]Bikkina, M., M.G. Larson, and D. Levy, Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med,
1992. 117(12): p. 990-6.
[2]Manolio, T.A., et al., Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll
Cardiol, 1994. 23(4): p. 916-25.
[3]Hirose, H., et al., Cardiac mortality of premature ventricular complexes in
healthy people in Japan. J Cardiol, 2010. 56(1): p. 23-6.
[4]Yang, J., et al., Characteristics of unselected high-burden premature ventricular contraction patients. Pacing Clin Electrophysiol, 2014. 37(12): p. 1671-80.
[5]Wang, Y., et al., Cellular mechanism of premature ventricular contraction-induced cardiomyopathy. Heart Rhythm, 2014. 11(11): p. 2064-72.
[6]Kennedy, H.L., et al., Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med, 1985. 312(4): p.
193-7.
[7]Epstein, A.E., et al., Mortality following ventricular arrhythmia suppression
by encainide, flecainide, and moricizine after myocardial infarction. The original
design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA, 1993.
270(20): p. 2451-5.
[8]Mason, J.W., A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias.
Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N
Engl J Med, 1993. 329(7): p. 445-51.
[9]Abdalla, I.S., et al., Relation between ventricular premature complexes and
sudden cardiac death in apparently healthy men. Am J Cardiol, 1987. 60(13): p.
1036-42.
[10].Hedblad, B., et al., Survival and incidence of myocardial infarction in
men with ambulatory ECG-detected frequent and complex ventricular arrhythmias.
10 year follow-up of the 'Men born 1914' study in Malmo, Sweden. Eur Heart J,
1997. 18(11): p. 1787-95.
[11].Ataklte, F., et al., Meta-analysis of ventricular premature complexes and
their relation to cardiac mortality in general populations. Am J Cardiol, 2013. 112
(8): p. 1263-70.
[12].Dukes, J.W., et al., Ventricular Ectopy as a Predictor of Heart Failure and
Death. J Am Coll Cardiol, 2015. 66(2): p. 101-9.
[13].Bogun, F., et al., Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention.
Heart Rhythm, 2007. 4(7): p. 863-7.
[14].Aronow, W.S., et al., Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in
elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol,
1990. 66(4): p. 423-8.
[15].Hallstrom, A.P., et al., An antiarrhythmic drug experience in 941 patients
resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol,
1991. 68(10): p. 1025-31.
[16].Morganroth, J. and J.E. Goin, Quinidine-related mortality in the shortto-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation,
1991. 84(5): p. 1977-83.
[17].Torp-Pedersen, C., et al., Dofetilide in patients with congestive heart
failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and
Mortality on Dofetilide Study Group. N Engl J Med, 1999. 341(12): p. 857-65.
[18].Waldo, A.L., et al., Effect of d-sotalol on mortality in patients with left
ventricular dysfunction after recent and remote myocardial infarction. The SWORD
Investigators. Survival With Oral d-Sotalol. Lancet, 1996. 348(9019): p. 7-12.
